S&P 500   4,298.86 (+0.11%)
DOW   33,876.78 (+0.13%)
QQQ   354.50 (+0.38%)
AAPL   180.96 (+0.22%)
MSFT   326.79 (+0.47%)
META   264.95 (+0.14%)
GOOGL   122.23 (+0.07%)
AMZN   123.43 (-0.66%)
TSLA   244.40 (+4.06%)
NVDA   387.70 (+0.68%)
NIO   7.74 (-0.64%)
BABA   85.50 (-0.74%)
AMD   124.92 (+3.20%)
T   15.96 (-0.75%)
F   13.74 (+1.18%)
MU   65.43 (+0.17%)
CGC   0.68 (-1.45%)
GE   106.30 (+0.22%)
DIS   91.95 (-0.63%)
AMC   4.77 (+1.92%)
PFE   38.97 (-0.31%)
PYPL   63.49 (-1.17%)
NFLX   420.02 (+2.60%)
S&P 500   4,298.86 (+0.11%)
DOW   33,876.78 (+0.13%)
QQQ   354.50 (+0.38%)
AAPL   180.96 (+0.22%)
MSFT   326.79 (+0.47%)
META   264.95 (+0.14%)
GOOGL   122.23 (+0.07%)
AMZN   123.43 (-0.66%)
TSLA   244.40 (+4.06%)
NVDA   387.70 (+0.68%)
NIO   7.74 (-0.64%)
BABA   85.50 (-0.74%)
AMD   124.92 (+3.20%)
T   15.96 (-0.75%)
F   13.74 (+1.18%)
MU   65.43 (+0.17%)
CGC   0.68 (-1.45%)
GE   106.30 (+0.22%)
DIS   91.95 (-0.63%)
AMC   4.77 (+1.92%)
PFE   38.97 (-0.31%)
PYPL   63.49 (-1.17%)
NFLX   420.02 (+2.60%)
S&P 500   4,298.86 (+0.11%)
DOW   33,876.78 (+0.13%)
QQQ   354.50 (+0.38%)
AAPL   180.96 (+0.22%)
MSFT   326.79 (+0.47%)
META   264.95 (+0.14%)
GOOGL   122.23 (+0.07%)
AMZN   123.43 (-0.66%)
TSLA   244.40 (+4.06%)
NVDA   387.70 (+0.68%)
NIO   7.74 (-0.64%)
BABA   85.50 (-0.74%)
AMD   124.92 (+3.20%)
T   15.96 (-0.75%)
F   13.74 (+1.18%)
MU   65.43 (+0.17%)
CGC   0.68 (-1.45%)
GE   106.30 (+0.22%)
DIS   91.95 (-0.63%)
AMC   4.77 (+1.92%)
PFE   38.97 (-0.31%)
PYPL   63.49 (-1.17%)
NFLX   420.02 (+2.60%)
S&P 500   4,298.86 (+0.11%)
DOW   33,876.78 (+0.13%)
QQQ   354.50 (+0.38%)
AAPL   180.96 (+0.22%)
MSFT   326.79 (+0.47%)
META   264.95 (+0.14%)
GOOGL   122.23 (+0.07%)
AMZN   123.43 (-0.66%)
TSLA   244.40 (+4.06%)
NVDA   387.70 (+0.68%)
NIO   7.74 (-0.64%)
BABA   85.50 (-0.74%)
AMD   124.92 (+3.20%)
T   15.96 (-0.75%)
F   13.74 (+1.18%)
MU   65.43 (+0.17%)
CGC   0.68 (-1.45%)
GE   106.30 (+0.22%)
DIS   91.95 (-0.63%)
AMC   4.77 (+1.92%)
PFE   38.97 (-0.31%)
PYPL   63.49 (-1.17%)
NFLX   420.02 (+2.60%)
OTCMKTS:ARKAY

Arkema (ARKAY) Stock Forecast, Price & News

$89.54
-2.61 (-2.83%)
(As of 06/9/2023 ET)
Compare
Today's Range
$89.54
$90.11
50-Day Range
$87.44
$99.61
52-Week Range
$67.88
$114.22
Volume
1,652 shs
Average Volume
3,080 shs
Market Capitalization
$6.72 billion
P/E Ratio
8.47
Dividend Yield
3.46%
Price Target
$104.00

ARKAY stock logo

About Arkema (OTCMKTS:ARKAY) Stock

Arkema SA engages in manufacturing and supply of chemical products. It operates through followings segments: High Performance Materials, Industrials Specialties, and Coating Solutions. The High Performance Materials segment includes the Technical Polymers, Filtration and Adsorption and Organic Peroxides business units and provides solutions with high value added, used in varied sectors such as transportation, oil extraction, renewable energies, consumer goods, electronics, construction, coatings, and water treatment. The Industrials Specialties segment groups the following business units: thiochemicals, fluorochemicals, polymethyl methacrylate, and hydrogen peroxides. The Coating Solutions segment proposes solutions for decorative paints, industrial coatings, adhesives, and high-growth acrylic applications. The company was founded on January 31, 2003 and is headquartered in Colombes, France.

Receive ARKAY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Arkema and its competitors with MarketBeat's FREE daily newsletter.

ARKAY Stock News Headlines

Vickie L. Arkema
Pentagon Consultant—Here's how Biden Wins Landslide Re-election
—but also hand Joe Biden a landslide re-election win. What would America look like if we slide further towards Socialism? Full story and 4 steps you can take,
What Wall Street expects from Arkema (spons ADRs)'s earnings
Arkema S.A. (OTCMKTS:ARKAY) Short Interest Down 28.6% in March
Brokerages Set Arkema S.A. (OTCMKTS:ARKAY) PT at $100.20
The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
Should Value Investors Buy Arkema (ARKAY) Stock?
ArKay Beverages and Walmart
Latest ArKay Zero Poof News
Are Investors Undervaluing Arkema (ARKAY) Right Now?
Here's Why Arkema SA (ARKAY) Looks Ripe for Bottom Fishing
3 Reasons Why Arkema SA (ARKAY) Is a Great Growth Stock
See More Headlines

ARKAY Price History

ARKAY Company Calendar

Last Earnings
5/05/2023
Ex-Dividend for 6/1 Dividend
5/11/2023
Dividend Payable
6/01/2023
Today
6/09/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Private households
Sub-Industry
N/A
Current Symbol
OTCMKTS:ARKAY
CIK
N/A
Employees
21,100
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$104.00
High Stock Price Forecast
$126.00
Low Stock Price Forecast
$79.00
Forecasted Upside/Downside
+16.1%
Consensus Rating
Hold
Rating Score (0-4)
2.25
Research Coverage
8 Analysts

Profitability

Net Income
$1.02 billion
Pretax Margin
10.56%

Debt

Sales & Book Value

Annual Sales
$12.17 billion
Cash Flow
$26.10 per share
Book Value
$103.04 per share

Miscellaneous

Free Float
N/A
Market Cap
$6.72 billion
Optionable
Not Optionable
Beta
1.40

Key Executives

  • Thierry le Hénaff
    Chairman & Chief Executive Officer
  • Marc Schuller
    Chief Operating Officer
  • Marie-José Donsion
    Chief Financial Officer
  • Armand Ajdari
    Chief Technology Officer
  • Vincent André Jean Legros
    Executive Vice President-Bostik













ARKAY Stock - Frequently Asked Questions

Should I buy or sell Arkema stock right now?

8 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Arkema in the last twelve months. There are currently 2 sell ratings, 2 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" ARKAY shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ARKAY, but not buy additional shares or sell existing shares.
View ARKAY analyst ratings
or view top-rated stocks.

What is Arkema's stock price forecast for 2023?

8 brokers have issued twelve-month price objectives for Arkema's shares. Their ARKAY share price forecasts range from $79.00 to $126.00. On average, they predict the company's share price to reach $104.00 in the next year. This suggests a possible upside of 16.1% from the stock's current price.
View analysts price targets for ARKAY
or view top-rated stocks among Wall Street analysts.

How have ARKAY shares performed in 2023?

Arkema's stock was trading at $89.78 at the start of the year. Since then, ARKAY stock has decreased by 0.3% and is now trading at $89.54.
View the best growth stocks for 2023 here
.

Are investors shorting Arkema?

Arkema saw a drop in short interest during the month of May. As of May 15th, there was short interest totaling 400 shares, a drop of 69.2% from the April 30th total of 1,300 shares. Based on an average daily volume of 4,000 shares, the days-to-cover ratio is currently 0.1 days.
View Arkema's Short Interest
.

How were Arkema's earnings last quarter?

Arkema S.A. (OTCMKTS:ARKAY) issued its quarterly earnings data on Friday, May, 5th. The basic materials company reported $2.33 earnings per share for the quarter. The basic materials company earned $2.71 billion during the quarter. Arkema had a trailing twelve-month return on equity of 12.81% and a net margin of 6.91%.

How often does Arkema pay dividends? What is the dividend yield for Arkema?

Arkema declared a dividend on Saturday, May 6th. Investors of record on Friday, May 12th will be given a dividend of $3.0335 per share on Thursday, June 1st. This represents a yield of 3.3%. The ex-dividend date of this dividend is Thursday, May 11th. This is a positive change from the stock's previous dividend of $2.67.
Read our dividend analysis for ARKAY
.

Is Arkema a good dividend stock?

Arkema (OTCMKTS:ARKAY) pays an annual dividend of $3.10 per share and currently has a dividend yield of 3.44%. The dividend payout ratio is 29.33%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, ARKAY will have a dividend payout ratio of 25.79% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for ARKAY.

What is Arkema's stock symbol?

Arkema trades on the OTCMKTS under the ticker symbol "ARKAY."

How do I buy shares of Arkema?

Shares of ARKAY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Arkema's stock price today?

One share of ARKAY stock can currently be purchased for approximately $89.54.

How much money does Arkema make?

Arkema (OTCMKTS:ARKAY) has a market capitalization of $6.72 billion and generates $12.17 billion in revenue each year. The basic materials company earns $1.02 billion in net income (profit) each year or $10.57 on an earnings per share basis.

How many employees does Arkema have?

The company employs 21,100 workers across the globe.

How can I contact Arkema?

Arkema's mailing address is 420 rue d`Estienne d Orves, Colombes Cedex I0, 92700. The official website for the company is www.arkema.com. The basic materials company can be reached via phone at (314) 900-8080, via email at sophi.fouillat@arkema.com, or via fax at 33-1-49-00-83-96.

This page (OTCMKTS:ARKAY) was last updated on 6/9/2023 by MarketBeat.com Staff

My Account -